XML 37 R23.htm IDEA: XBRL DOCUMENT v3.25.1
FAIR VALUE MEASUREMENTS (Tables)
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets Measured on Recurring Basis
As of March 31, 2025 and December 31, 2024, the assets and liabilities measured at fair value on a recurring basis were as set forth in the table below:
 
 
 
(In millions)		March 31, 2025Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs
(Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$7.7 $7.7 $— $— 
Forward currency contracts3.1 — 3.1 — 
Total assets$10.8 $7.7 $3.1 $— 
Liabilities:
Share swap transaction$1.2 $1.2 $— $— 
Total liabilities$1.2 $1.2 $— $— 
(In millions)December 31, 2024Quoted Prices in Active Markets for Identical Assets (Level 1)Significant Other Observable Inputs (Level 2)Significant Unobservable Inputs (Level 3)
Assets:
Cash equivalents$5.0 $5.0 $— $— 
Total assets$5.0 $5.0 $— $— 
Liabilities:
Share swap transaction$2.5 $2.5 $— $— 
Contingent payments related to acquisition$5.0 $— $— $5.0 
Total liabilities$7.5 $2.5 $— $5.0 
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation The following table provides a roll-forward of the contingent consideration liability, which is included in "Accrued expenses and other current liabilities" as of March 31, 2025 and March 31, 2024:
First Quarter Ended
(In millions)March 31, 2025March 31, 2024
Fair value at beginning of period$5.0 $3.0 
Adjustments to prior year acquisition— 1.3 
Change in fair value recognized in earnings— 0.2 
Payments(5.0)— 
Fair value at end of period$— $4.5